PG
TMO icon

Pendal Group’s Thermo Fisher Scientific TMO Stock Holding History

Pendal Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$195M Sell
353,883
-3,253
-0.9% -$1.72M 1.68% 17
2022
Q3 		$181M Buy
357,136
+3,977
+1% +$2.23M 1.76% 17
2022
Q2 		$192M Buy
353,159
+9,647
+3% +$5.31M 1.88% 12
2022
Q1 		$203M Buy
343,512
+40,362
+13% +$23.2M 1.67% 14
2021
Q4 		$202M Sell
303,150
-108,272
-26% -$67.6M 1.62% 12
2021
Q3 		$235M Buy
411,422
+185,074
+82% +$102M 1.94% 9
2021
Q2 		$114M Buy
226,348
+2,671
+1% +$1.26M 1.05% 33
2021
Q1 		$102M Buy
223,677
+24,370
+12% +$11.6M 1% 39
2020
Q4 		$92.8M Sell
199,307
-65,865
-25% -$30.9M 0.97% 37
2020
Q3 		$117M Sell
265,172
-31,951
-11% -$13.2M 1.43% 16
2020
Q2 		$108M Sell
297,123
-8,499
-3% -$2.85M 1.47% 14
2020
Q1 		$86.7M Sell
305,622
-18,586
-6% -$5.86M 1.48% 17
2019
Q4 		$105M Sell
324,208
-8,230
-2% -$2.5M 1.38% 18
2019
Q3 		$96.8M Sell
332,438
-208
-0.1% -$59.6K 1.26% 26
2019
Q2 		$86M Buy
332,646
+10,526
+3% +$2.9M 1.2% 21
2019
Q1 		$88.2M Sell
322,120
-42,522
-12% -$10.6M 1.21% 24
2018
Q4 		$70.9M Sell
364,642
-5,451
-1% -$1.28M 1.13% 30
2018
Q3 		$90.3M Buy
+370,093
New +$85.1M 1.23% 24

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pendal Group's TMO Position: Q4 2022 in Review

Pendal Group reduced its Thermo Fisher Scientific (TMO) stake by 0.91% in Q4 2022, selling an estimated $1.72M and leaving 353,883 shares worth $195M. The position accounts for 1.68% of the portfolio, ranked #17.

Pendal Group first reported a position in TMO in Q3 2018 and has held it in 18 quarters since. The position peaked at $235M in Q3 2021. 2,374 funds tracked by Wall St. Rank hold TMO as of Q4 2022.

  • Pendal Group held 353,883 shares of Thermo Fisher Scientific worth $195M as of Q4 2022.
  • Pendal Group sold 3,253 Thermo Fisher Scientific shares in Q4 2022, an estimated $1.72M.
  • Thermo Fisher Scientific made up 1.68% of Pendal Group's portfolio in Q4 2022, its #17 holding.
  • Pendal Group first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 18 quarters since.
  • Pendal Group's Thermo Fisher Scientific position peaked at $235M in Q3 2021.
  • 2,374 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2022.

Based on Pendal Group's 13F filing for Q4 2022, filed 19 Jan 2023.